Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

320.42

+1.51 (0.47%)

At close: Mar 17, 2026, 4:00 PM EDT

320.14

-0.28 (-0.09%)

After-hours: Mar 17, 2026, 5:43 PM EDT

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	42,495	52,639	30,424	24,078	29,451	20,380
Market Cap Growth	33.03%	73.02%	26.36%	-18.24%	44.51%	34.68%
Enterprise Value	42,555	50,964	28,984	22,903	28,537	18,902
Last Close Price	320.42	397.65	235.31	191.41	237.65	169.58
PE Ratio	137.52	170.67	-107.94	-54.38	-25.55	-23.55
Forward PE	48.10	60.03	-	-	-	-
PS Ratio	11.44	14.17	13.53	13.17	28.39	24.14
PB Ratio	53.75	66.70	453.50	-109.13	-186.13	34.65
P/TBV Ratio	54.68	67.86	447.73	-108.36	-182.78	34.15
P/FCF Ratio	91.31	113.11	-714.37	574.04	-48.02	-28.38
P/OCF Ratio	81.09	100.44	-3660.27	231.17	-54.41	-31.76
EV/Sales Ratio	11.46	13.72	12.89	12.53	27.51	22.39
EV/EBITDA Ratio	76.37	91.46	-241.10	-100.40	-38.53	-28.59
EV/EBIT Ratio	84.84	101.61	-163.86	-81.16	-36.35	-26.67
EV/FCF Ratio	91.44	109.51	-680.55	546.02	-46.53	-26.32
Debt / Equity Ratio	1.56	1.56	18.69	-5.73	-8.08	1.63
Debt / EBITDA Ratio	2.29	2.29	-10.78	-5.72	-1.78	-1.51
Debt / FCF Ratio	2.75	2.75	-30.43	31.12	-2.15	-1.39
Net Debt / Equity Ratio	-2.07	-2.07	-20.84	5.14	5.51	-2.44
Net Debt / EBITDA Ratio	-2.92	-2.92	11.63	4.97	1.18	2.17
Net Debt / FCF Ratio	-3.50	-3.50	32.84	-27.03	1.42	2.00
Asset Turnover	0.81	0.81	0.56	0.50	0.29	0.24
Inventory Turnover	8.46	8.46	3.86	2.85	1.57	1.73
Quick Ratio	2.51	2.51	2.61	2.86	3.16	3.79
Current Ratio	2.76	2.76	2.78	3.08	3.51	4.04
Return on Equity (ROE)	131.93%	73.28%	362.29%	232.40%	-526.14%	-106.31%
Return on Assets (ROA)	10.58%	10.58%	-3.23%	-7.77%	-21.92%	-20.12%
Return on Invested Capital (ROIC)	63.85%	63.85%	-20.29%	-43.01%	-108.72%	-76.10%
Return on Capital Employed (ROCE)	15.31%	15.31%	-5.98%	-10.01%	-27.42%	-24.57%
Earnings Yield	0.74%	0.59%	-0.93%	-1.84%	-3.91%	-4.25%
FCF Yield	1.10%	0.88%	-0.14%	0.17%	-2.08%	-3.52%
Buyback Yield / Dilution	-0.47%	-0.47%	-1.00%	-0.61%	-0.88%	-1.21%

Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q